We are pleased to announce that Hemera has been selected as one of the 11 finalists for the Italian Master Startup Award (IMSA), the prestigious prize dedicated to scale-ups born from academic research. The award is promoted by the national network of university incubators PNICube and organized in collaboration with I3P, the incubator of the Politecnico di Torino.
Hemera Pharma stands out for the development of REMaST®, a groundbreaking cell therapy that aims to become the world’s first capable of regenerating neural tissue—offering an innovative solution for treating spinal cord injuries.
The final event will be held on September 25, 2024, at the Agorà Hall of I3P on the Politecnico Campus, as part of the side events of Italian Tech Week. This is a unique opportunity to connect with major companies, investors, and key players in the innovation ecosystem.